zardaverine has been researched along with Chronic Lung Injury in 1 studies
zardaverine: structure given in first source
zardaverine : A pyridazinone derivative in which pyridazin-3(2H)-one is substituted at C-6 with a 4-(difluoromethoxy)-3-methoxyphenyl group. It is a phosphodiesterase inhibitor, selective for PDE3 and 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Seeger, W | 1 |
| Hansen, T | 1 |
| Rössig, R | 1 |
| Schmehl, T | 1 |
| Schütte, H | 1 |
| Krämer, HJ | 1 |
| Walmrath, D | 1 |
| Weissmann, N | 1 |
| Grimminger, F | 1 |
| Suttorp, N | 1 |
1 other study available for zardaverine and Chronic Lung Injury
| Article | Year |
|---|---|
Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability--effect of adenylate cyclase stimulation and phosphodiesterase inhibition.
Topics: Adenylyl Cyclases; Alprostadil; Animals; Capillary Permeability; Colforsin; Endothelium, Vascular; E | 1995 |